dextroamphetamine has been researched along with Hallucinations in 17 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 6.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| " Lysergic acid diethylamide and dimethyltryptamine could be distinguished from saline, chlorpromazine, d-amphetamine sulfate, and bromo-lysergic acid diethylamide by the increased frequency of spasms, stereotypy, bump, and tracking." | 3.65 | The effects of hallucinogens on blind monkeys. ( Brewster, JM; Jarvik, ME; Johnson, CA; Siegel, RK, 1976) |
| "The clinical symptoms of cataplexy, sleep paralysis, hypnogogic hallucinations, daily naps, and sleep attacks all showed significant improvements." | 2.66 | The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. ( Brown, D; Brown, L; Hirschowitz, J; Scharf, MB; Woods, M, 1985) |
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 2.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| "Narcolepsy is a disabling disease with a prevalence of 0." | 2.44 | Pediatric narcolepsy. ( Husain, AM; Peterson, PC, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (82.35) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krishnamurthy, VB | 1 |
| Nallamothu, V | 1 |
| Singareddy, R | 1 |
| SOURS, JA | 1 |
| Peterson, PC | 1 |
| Husain, AM | 1 |
| Roth, WT | 1 |
| Ellison, GD | 1 |
| Eison, MS | 1 |
| Nielsen, EB | 1 |
| Lyon, M | 1 |
| Ellison, G | 1 |
| Kales, A | 1 |
| Cadieux, RJ | 1 |
| Soldatos, CR | 1 |
| Bixler, EO | 1 |
| Schweitzer, PK | 1 |
| Prey, WT | 1 |
| Vela-Bueno, A | 1 |
| Parameshwar, E | 1 |
| Siegel, RK | 1 |
| Brewster, JM | 1 |
| Johnson, CA | 1 |
| Jarvik, ME | 1 |
| Collins, WE | 1 |
| Scharf, MB | 1 |
| Brown, D | 1 |
| Woods, M | 1 |
| Brown, L | 1 |
| Hirschowitz, J | 1 |
| Parkes, JD | 1 |
| Fenton, GW | 1 |
| Vogel, GW | 1 |
| Thatcher, K | 1 |
| Kappeler, T | 1 |
| Wisecup, P | 1 |
| Fischer, R | 1 |
| Angrist, B | 1 |
| Sathananthan, G | 1 |
| Wilk, S | 1 |
| Gershon, S | 1 |
| Malitz, S | 1 |
| Kanzler, M | 1 |
| Dandiya, PC | 1 |
| Menon, MK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treating Comorbid Depression of Patients With Narcolepsy by Intermittent Theta Burst Stimulation: A Preliminary Study[NCT05884112] | 105 participants (Anticipated) | Interventional | 2023-02-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dextroamphetamine and Hallucinations
| Article | Year |
|---|---|
NARCOLEPSY AND OTHER DISTURBANCES IN THE SLEEP-WAKING RHYTHM: A STUDY OF 115 CASES WITH REVIEW OF THE LITERATURE.
Topics: Black People; Cataplexy; Craniocerebral Trauma; Depression; Dextroamphetamine; Encephalitis; Halluci | 1963 |
Pediatric narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Child; Dextroamphetamine; Ghreli | 2008 |
REM deprivation. 3. Dreaming and psychosis.
Topics: Anxiety; Behavior; Depression; Dextroamphetamine; Dreams; Drive; Eye Movements; Hallucinations; Huma | 1968 |
Effects of drugs on perception in man.
Topics: Afterimage; Amobarbital; Amphetamine; Animals; Antidepressive Agents; Auditory Perception; Barbitura | 1970 |
2 trials available for dextroamphetamine and Hallucinations
| Article | Year |
|---|---|
The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Cataplexy; Clinical Trials as Topic; Dextroamphetamin | 1985 |
Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Dextroamphetamine; Electroencephalography; Eva | 1973 |
11 other studies available for dextroamphetamine and Hallucinations
| Article | Year |
|---|---|
An interesting case of late age at onset of narcolepsy with cataplexy.
Topics: Amphetamine; Cataplexy; Central Nervous System Stimulants; Dextroamphetamine; Diagnosis, Differentia | 2014 |
The effect of LSD, mescaline, and D-amphetamine on the evoked "secondary discharge".
Topics: Animals; Brain; Cats; Dextroamphetamine; Evoked Potentials; Hallucinations; Humans; Lysergic Acid Di | 1966 |
Continuous amphetamine intoxication: an animal model of the acute psychotic episode.
Topics: Animals; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Disease Models, Animal; Dopamine; Hal | 1983 |
Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis.
Topics: Animals; Behavior, Animal; Chlorocebus aethiops; Dextroamphetamine; Drug Implants; Grooming; Halluci | 1983 |
Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics.
Topics: Adolescent; Adult; Aged; Catalepsy; Dextroamphetamine; Electroencephalography; Female; Hallucination | 1982 |
Private prescribing of controlled drugs needs closer scrutiny.
Topics: Delusions; Dextroamphetamine; Drug Prescriptions; Female; Hallucinations; Humans; Methadone; Private | 1995 |
The effects of hallucinogens on blind monkeys.
Topics: Animals; Behavior, Animal; Blindness; Chlorpromazine; Dextroamphetamine; Exploratory Behavior; Hallu | 1976 |
Some effects of sleep deprivation on tracking performance in static and dynamic environments.
Topics: Acceleration; Aerospace Medicine; Dextroamphetamine; Hallucinations; Humans; Male; Motor Skills; Sle | 1977 |
Personality trait dependent performance under psilocybin. II.
Topics: Autonomic Nervous System; Cognition; Dextroamphetamine; Dissociative Disorders; Female; Hallucinatio | 1970 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depressio | 1974 |
Interaction of asarone with mescaline, amphetamine and tremorine.
Topics: Animals; Atropine; Chlorpromazine; Dextroamphetamine; Hallucinations; Humans; Mescaline; Mice; Oils, | 1965 |